81154-13-4

Basic information

• Product Name: AKOS B018312
• Synonyms: CHEMBRDG-BB 3018312;ART-CHEM-BB B018312;AKOS B018312;(5E)-5-(4-hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one;Albb-009169;(5E)-5-(4-hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one(SALTDATA: FREE);(5E)-5-(4-hydroxybenzylidene)-2-thioxo-thiazolidin-4-one;(5E)-5-[(4-hydroxyphenyl)methylene]-2-thioxo-4-thiazolidinone
• CAS NO: 81154-13-4
• Molecular Formula: C₁₀H₇NO₂S₂
• Molecular Weight: 237.3
• Mol File: 81154-13-4.mol

Chemical Properties

• Boiling Point: 416.8°C at 760 mmHg
• Flash Point: 205.9°C
• Appearance: /
• Density: 1.56g/cm³
• Vapor Pressure: 1.53E-07mmHg at 25°C
• Refractive Index: 1.776
• CAS DataBase Reference: AKOS B018312(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS B018312(81154-13-4)
• EPA Substance Registry System: AKOS B018312(81154-13-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 81154-13-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
AKOS B018312 is used as a potential therapeutic agent for the treatment of mental health disorders or neurological diseases due to its psychoactive and stimulant effects as a derivative of methoxy-substituted phenethylamine.
Used in Research and Development:
AKOS B018312 is used as a subject of preclinical studies to explore its potential mechanisms of action and pharmacological properties, with the aim of understanding its therapeutic potential and safety profile for future clinical applications.

InChI:InChI=1/C10H7NO2S2/c12-7-3-1-6(2-4-7)5-8-9(13)11-10(14)15-8/h1-5,12H,(H,11,13,14)/b8-5+

Upstream product

• 141-84-4 2-thioxo-4-thiazolidinone 
• 123-08-0 4-hydroxy-benzaldehyde 

Relevant articles and documents

Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase

A series of rhodanine derivatives RB1–RB23 were synthesized through a two-round screening. Their Mycobacterial tuberculosis (Mtb) InhA inhibitory activity and Mtb growth blocking capability were evaluated. The most potent hit compound RB23 indicated compa

Microwave induced synthesis of the thiazolidine-2,4-dione motif and the efficient solvent free-solid phase parallel syntheses of 5-benzylidene- thiazolidine-2,4-dione and 5-benzylidene-2-thioxo-thiazolidine-4-one compounds

Novel microwave induced method for the synthesis of thiazolidine-2,4-dione motif under solvent phase conditions is developed. Further we report an efficient, microwave assisted method for the parallel syntheses of biologically important 5-benzylidene-thiazolidine-2,4-dione and 5-benzylidene-2- thioxothiazolidine-4-one compounds under solid-phase and solvent-free conditions. A comparative study between the developed microwave methods and the conventional methods is described. We have also illustrated the possible mechanism behind to address the reason why piperidine, acetic acid and silica gel enhanced the Knoevenagel condensation reaction.

Method for treating multiple sclerosis

Provided is a method of treating multiple sclerosis employing certain aryl-substituted rhodanines.

COMPOUNDS USEFUL AS HYPOGLYCEMIC AGENTS AND FOR TREATING ALZHEIMER'S DISEASE

Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulation

Aryl-substituted rhodanine derivatives

Provided are certain aryl-substituted rhodanine derivatives, treatment methods and pharmaceutical formulations thereof.

Method of treating type I diabetes

Provided is a method for treating Type I diabetes in mammals utilizing certain aryl-substituted rhodanine derivatives.